Heterozygous mutations affecting the protein kinase domain of CDK13 cause a syndromic form of developmental delay and intellectual disability
<p>INTRODUCTION: Recent evidence has emerged linking mutations in CDK13 to syndromic congenital heart disease. We present here genetic and phenotypic data pertaining to 16 individuals with CDK13 mutations.</p><p>METHODS: Patients were investigated by exome sequencing, hav...
Main Authors: | , , , , |
---|---|
Format: | Journal article |
Published: |
BMJ Publishing Group
2017
|
_version_ | 1797069497260048384 |
---|---|
author | Hamilton, M Caswell, R Canham, N Twigg, S Wilkie, A |
author_facet | Hamilton, M Caswell, R Canham, N Twigg, S Wilkie, A |
author_sort | Hamilton, M |
collection | OXFORD |
description | <p>INTRODUCTION: Recent evidence has emerged linking mutations in CDK13 to syndromic congenital heart disease. We present here genetic and phenotypic data pertaining to 16 individuals with CDK13 mutations.</p><p>METHODS: Patients were investigated by exome sequencing, having presented with developmental delay and additional features suggestive of a syndromic cause.</p><p>RESULTS: Our cohort comprised 16 individuals aged four to 16 years. All had developmental delay, including six with autism spectrum disorder. Common findings included feeding difficulties (15/16), structural cardiac anomalies (9/16), seizures (4/16) and abnormalities of the corpus callosum (4/11 patients who had undergone MRI). All had craniofacial dysmorphism, with common features including short, upslanting palpebral fissures, hypertelorism or telecanthus, medial epicanthic folds, low-set, posteriorly rotated ears and a small mouth with thin upper lip vermilion. Fifteen patients had predicted missense mutations, including five identical p.(Asn842Ser) substitutions and two p.(Gly717Arg) substitutions. One patient had a canonical splice acceptor site variant (c.2898-1G>A). All mutations were located within the protein kinase domain of CDK13. The affected amino acids are highly conserved, and in silico analyses including comparative protein modelling predict that they will interfere with protein function. The location of the missense mutations in a key catalytic domain suggest that they are likely to cause loss of catalytic activity but retention of cyclin K binding, resulting in a dominant negative mode of action. Although the splice site mutation was predicted to produce a stable internally deleted protein, this was not supported by expression studies in lymphoblastoid cells. A loss of function contribution to the underlying pathological mechanism therefore cannot be excluded, and the clinical significance of this variant remains uncertain.</p><p>CONCLUSIONS These patients demonstrate that heterozygous, likely dominant negative mutations affecting the protein kinase domain of the CDK13 gene result in a recognisable, syndromic form of intellectual disability, with or without congenital heart disease.</p> |
first_indexed | 2024-03-06T22:25:20Z |
format | Journal article |
id | oxford-uuid:567a0940-19b2-49e5-a6c3-a58cded28398 |
institution | University of Oxford |
last_indexed | 2024-03-06T22:25:20Z |
publishDate | 2017 |
publisher | BMJ Publishing Group |
record_format | dspace |
spelling | oxford-uuid:567a0940-19b2-49e5-a6c3-a58cded283982022-03-26T16:50:32ZHeterozygous mutations affecting the protein kinase domain of CDK13 cause a syndromic form of developmental delay and intellectual disabilityJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:567a0940-19b2-49e5-a6c3-a58cded28398Symplectic Elements at OxfordBMJ Publishing Group2017Hamilton, MCaswell, RCanham, NTwigg, SWilkie, A<p>INTRODUCTION: Recent evidence has emerged linking mutations in CDK13 to syndromic congenital heart disease. We present here genetic and phenotypic data pertaining to 16 individuals with CDK13 mutations.</p><p>METHODS: Patients were investigated by exome sequencing, having presented with developmental delay and additional features suggestive of a syndromic cause.</p><p>RESULTS: Our cohort comprised 16 individuals aged four to 16 years. All had developmental delay, including six with autism spectrum disorder. Common findings included feeding difficulties (15/16), structural cardiac anomalies (9/16), seizures (4/16) and abnormalities of the corpus callosum (4/11 patients who had undergone MRI). All had craniofacial dysmorphism, with common features including short, upslanting palpebral fissures, hypertelorism or telecanthus, medial epicanthic folds, low-set, posteriorly rotated ears and a small mouth with thin upper lip vermilion. Fifteen patients had predicted missense mutations, including five identical p.(Asn842Ser) substitutions and two p.(Gly717Arg) substitutions. One patient had a canonical splice acceptor site variant (c.2898-1G>A). All mutations were located within the protein kinase domain of CDK13. The affected amino acids are highly conserved, and in silico analyses including comparative protein modelling predict that they will interfere with protein function. The location of the missense mutations in a key catalytic domain suggest that they are likely to cause loss of catalytic activity but retention of cyclin K binding, resulting in a dominant negative mode of action. Although the splice site mutation was predicted to produce a stable internally deleted protein, this was not supported by expression studies in lymphoblastoid cells. A loss of function contribution to the underlying pathological mechanism therefore cannot be excluded, and the clinical significance of this variant remains uncertain.</p><p>CONCLUSIONS These patients demonstrate that heterozygous, likely dominant negative mutations affecting the protein kinase domain of the CDK13 gene result in a recognisable, syndromic form of intellectual disability, with or without congenital heart disease.</p> |
spellingShingle | Hamilton, M Caswell, R Canham, N Twigg, S Wilkie, A Heterozygous mutations affecting the protein kinase domain of CDK13 cause a syndromic form of developmental delay and intellectual disability |
title | Heterozygous mutations affecting the protein kinase domain of CDK13 cause a syndromic form of developmental delay and intellectual disability |
title_full | Heterozygous mutations affecting the protein kinase domain of CDK13 cause a syndromic form of developmental delay and intellectual disability |
title_fullStr | Heterozygous mutations affecting the protein kinase domain of CDK13 cause a syndromic form of developmental delay and intellectual disability |
title_full_unstemmed | Heterozygous mutations affecting the protein kinase domain of CDK13 cause a syndromic form of developmental delay and intellectual disability |
title_short | Heterozygous mutations affecting the protein kinase domain of CDK13 cause a syndromic form of developmental delay and intellectual disability |
title_sort | heterozygous mutations affecting the protein kinase domain of cdk13 cause a syndromic form of developmental delay and intellectual disability |
work_keys_str_mv | AT hamiltonm heterozygousmutationsaffectingtheproteinkinasedomainofcdk13causeasyndromicformofdevelopmentaldelayandintellectualdisability AT caswellr heterozygousmutationsaffectingtheproteinkinasedomainofcdk13causeasyndromicformofdevelopmentaldelayandintellectualdisability AT canhamn heterozygousmutationsaffectingtheproteinkinasedomainofcdk13causeasyndromicformofdevelopmentaldelayandintellectualdisability AT twiggs heterozygousmutationsaffectingtheproteinkinasedomainofcdk13causeasyndromicformofdevelopmentaldelayandintellectualdisability AT wilkiea heterozygousmutationsaffectingtheproteinkinasedomainofcdk13causeasyndromicformofdevelopmentaldelayandintellectualdisability |